Litt’s Drug profile for Alitretinoin


GeriatricPediatric
  • Trade Name: Panretin (Ligand)
  • Indications: Kaposi’s sarcoma cutaneous lesions
  • Class: Retinoid
  • Half-life: N/A
  • See adverse reactions attributed to class:

    Retinoid

Please login to view the rest of this drug profile.

Page last updated 08/05/2026

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric